Theranos: Elizabeth Holmes denies misleading investors

Once valued at $9bn, the blood-testing startup Theranos collapsed after it was uncovered that its devices were flawed.

source https://www.aljazeera.com/economy/2021/12/7/elizabeth-holmes-resumes-cross-examination-at-theranos-trial